Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Dermatology Breakthroughs: From Psoriasis to Rosacea
This week's episode covers groundbreaking research in dermatology, from consensus guidelines for pustular psoriasis to novel treatments for atopic dermatitis and hidradenitis suppurativa.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Authors: Puig L, Carrascosa JM, Rivera R, et al.
Journal: Actas dermo-sifiliograficas, 2026 Mar
PMID: 41371399
DOI: 10.1016/j.ad.2025.104544
2. Association of the Triglyceride-Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis.
Authors: Bampali E, Chiotis S, Zgouridou A, et al.
Journal: Medicina (Kaunas, Lithuania), 2026 Feb 11
PMID: 41752760
DOI: 10.3390/medicina62020360
3. The exposomal imprint on rosacea: More than skin deep.
Authors: Grafanaki K, Bakoli Sgourou D, Maniatis A, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Mar
PMID: 41081484
DOI: 10.1111/jdv.70112
4. Nail dystrophy successfully treated with dupilumab in pediatric atopic dermatitis: case series and literature review.
Authors: Wang Q, Liu J, Yang G, et al.
Journal: Frontiers in immunology, 2026
PMID: 41782873
DOI: 10.3389/fimmu.2026.1668182
5. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.
Authors: Pálla S, Metyovinyi Z, Meznerics FA, et al.
Journal: International journal of dermatology, 2026 Mar
PMID: 41165034
DOI: 10.1111/ijd.70118
6. Systematic review of the epidemiology of acne vulgaris.
Authors: Heng AHS, Chew FT
Journal: Scientific reports, 2020 Apr 1
PMID: 32238884
DOI: 10.1038/s41598-020-62715-3
7. RB1 inactivation in cutaneous carcinomas.
Authors: Liv T, Touzé A, Schrama D, et al.
Journal: Histopathology, 2026 Mar
PMID: 41395640
DOI: 10.1111/his.70056
8. Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.
Authors: Sayed CJ, Kirby B, Garg A, et al.
Journal: Journal of the American Academy of Dermatology, 2026 Mar
PMID: 41248770
DOI: 10.1016/j.jaad.2025.11.031
9. Chromoblastomycosis.
Authors: Queiroz-Telles F, de Hoog S, Santos DW, et al.
Journal: Clinical microbiology reviews, 2017 Jan
PMID: 27856522
DOI: 10.1128/CMR.00032-16
10. Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results.
Authors: Thaçi D, Laquer V, Lynde C, et al.
Journal: The Journal of allergy and clinical immunology, 2026 Mar
PMID: 41232575
DOI: 10.1016/j.jaci.2025.08.034
Authors: Puig L, Carrascosa JM, Rivera R, et al.
Journal: Actas dermo-sifiliograficas, 2026 Mar
PMID: 41371399
DOI: 10.1016/j.ad.2025.104544
2. Association of the Triglyceride-Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis.
Authors: Bampali E, Chiotis S, Zgouridou A, et al.
Journal: Medicina (Kaunas, Lithuania), 2026 Feb 11
PMID: 41752760
DOI: 10.3390/medicina62020360
3. The exposomal imprint on rosacea: More than skin deep.
Authors: Grafanaki K, Bakoli Sgourou D, Maniatis A, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Mar
PMID: 41081484
DOI: 10.1111/jdv.70112
4. Nail dystrophy successfully treated with dupilumab in pediatric atopic dermatitis: case series and literature review.
Authors: Wang Q, Liu J, Yang G, et al.
Journal: Frontiers in immunology, 2026
PMID: 41782873
DOI: 10.3389/fimmu.2026.1668182
5. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.
Authors: Pálla S, Metyovinyi Z, Meznerics FA, et al.
Journal: International journal of dermatology, 2026 Mar
PMID: 41165034
DOI: 10.1111/ijd.70118
6. Systematic review of the epidemiology of acne vulgaris.
Authors: Heng AHS, Chew FT
Journal: Scientific reports, 2020 Apr 1
PMID: 32238884
DOI: 10.1038/s41598-020-62715-3
7. RB1 inactivation in cutaneous carcinomas.
Authors: Liv T, Touzé A, Schrama D, et al.
Journal: Histopathology, 2026 Mar
PMID: 41395640
DOI: 10.1111/his.70056
8. Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.
Authors: Sayed CJ, Kirby B, Garg A, et al.
Journal: Journal of the American Academy of Dermatology, 2026 Mar
PMID: 41248770
DOI: 10.1016/j.jaad.2025.11.031
9. Chromoblastomycosis.
Authors: Queiroz-Telles F, de Hoog S, Santos DW, et al.
Journal: Clinical microbiology reviews, 2017 Jan
PMID: 27856522
DOI: 10.1128/CMR.00032-16
10. Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results.
Authors: Thaçi D, Laquer V, Lynde C, et al.
Journal: The Journal of allergy and clinical immunology, 2026 Mar
PMID: 41232575
DOI: 10.1016/j.jaci.2025.08.034
